X-Cell Medical, Inc. Completes Enrollment For Clinical Trial Of ETHOS I Estradiol Eluting Stent

PRINCETON, N.J.--(BUSINESS WIRE)--Nov. 21, 2005--X-Cell Medical, Inc. announced today that the Company has completed enrollment in its multinational clinical trial to study the safety and effectiveness of the ETHOS I Coronary Stent System.